Cardiac involvement in mitochondrial DNA disease is common and requires multi-disciplinary management by cardiologists.
This review highlights the importance of recognizing and managing cardiac involvement in patients with mitochondrial DNA disease.
Mitochondrial disease refers to a heterogenous group of genetic disorders that result from dysfunction of the final common pathway of energy metabolism. Mitochondrial DNA mutations affect key components of the respiratory chain and account for the majority of mitochondrial disease in adults. Owing to critical dependence of the heart on oxidative metabolism, cardiac involvement in mitochondrial disease is common and may occur as the principal clinical manifestation or part of multisystem disease. Recent advances in our understanding of the clinical spectrum and genetic aetiology of cardiac involvement in mitochondrial DNA disease have important implications for cardiologists in terms of the investigation and multi-disciplinary management of patients.
Bates et al. (Thu,) conducted a review in Cardiac involvement in mitochondrial DNA disease. Cardiac involvement in mitochondrial DNA disease is common and requires multi-disciplinary management by cardiologists.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: